Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
JJ Ifthikharuddin, University of Rochester Identifier:
First received: April 24, 2006
Last updated: August 29, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)